Navigation Links
Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives
Date:5/28/2008

ent risk factor for CHD and ischemic stroke. Changes in biomarkers suggested a possible reduction in systemic inflammatory burden. In addition, GSK stated in February 2008 that the results of its randomized Phase 2/3 imaging trial of darapladib in coronary artery disease will be presented and published in the second half of 2008.

SYNCRIA(R): POSSIBLE PHASE 3 DECISION IN 2008

Syncria (albiglutide) is a novel long-acting form of GLP-1 (glucagon-like peptide 1) created by HGS using its proprietary albumin-fusion technology, and licensed to GSK in 2004. Syncria is generated from the genetic fusion of human albumin and GLP-1, a peptide hormone that acts throughout the body to help maintain normal blood-sugar levels and to control appetite. GSK is developing Syncria as a treatment for type 2 diabetes mellitus, and initiated a randomized Phase 2b dose-ranging clinical trial of Syncria in May 2007 in patients with type 2 diabetes. As a comparison, one group of patients is receiving Byetta (exenatide).

HGS is entitled to fees and milestone payments, some of which have already been received, that could amount to as much as $183 million, in addition to single-digit royalties on worldwide sales if Syncria is commercialized. HGS believes it is possible that GSK will reach a decision in 2008 regarding whether to advance Syncria to Phase 3 development.

HGS ANALYST DAY WEBCAST

HGS senior executives will provide an overview of the Company at its Analyst and Investor Meeting today in New York, starting at 12 noon Eastern time. The presentations will be webcast and may be accessed at http://www.hgsi.com. Investors interested in listening to the live webcast should log on before the presentations begin in order to download any software required. The archive of the presentations will be available for several days following the meeting.

ABOUT HUMAN GENOME SCIENCES

The mission of HGS is to app
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
2. St. Jude Finds Dancing Hair Cells Are Key to Humans Acute Hearing
3. Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases
4. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
5. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
6. First Human Implant of New Archus Orthopedics Facet Replacement System
7. Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials
8. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
9. Data Show SuperGens MP-470 is Safe in Humans
10. Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
11. CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... September 30, 2014 ... the "Glycobiology/Glycomics Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, ... and Reagents], Application (Immunology, Oncology) & by ... published by MarketsandMarkets, provides a detailed overview ... current market trends, and strategies impacting the ...
(Date:9/30/2014)... Sept. 30, 2014 The Chinese wound care ... and rise in the incidence of lifestyle diseases, coupled ... in affordability of better quality of wound care products ... Universal coverage of public health insurance schemes and increased ... demand. Based on the findings of primary and secondary ...
(Date:9/30/2014)... 30, 2014 BioStructures, LLC has been ... of Tissue Banks (AATB), it was announced today ... Accreditation follows an intensive nine-month process, ... AATB inspector.  It establishes that the level of ... meets or exceeds the standards set by the ...
Breaking Medicine Technology:Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4China Wound Care Market 2China Wound Care Market 3Biostructures, LLC Earns AATB Accreditation 2
... , , THOUSAND OAKS, Calif., Jan. 7 Amgen ... JP Morgan Global Healthcare Conference at 8:00 a.m. Pacific Time ... in San Francisco, Calif. Amgen Chairman and CEO Kevin ... presentation will be available over the Internet and can be ...
... , , TUCSON, Ariz., Jan. 7 ... Fletcher McCusker, Chairman and Chief Executive Officer, is scheduled to present ... First 2010 Micro Cap Conference on Monday, January 11, 2010 at ... is scheduled for 1:50 p.m. ET. , On Thursday, ...
Cached Medicine Technology:Amgen to Present at the 28th Annual JP Morgan Healthcare Conference 2Providence Service Corporation to Present at the Sidoti & Company, LLC Micro Cap Conference on Monday, January 11th and at the CJS Securities 'New Ideas for the New Year' Conference on Thursday, January 14th 2
(Date:9/30/2014)... Federally Qualified Health Centers (FQHCs) granted new patient ... higher rates than other primary care practices (non-FQHCs), ... to results of a new 10-state University of ... Care . , Using data from a previous ... the investigators found that FQHCs community health ...
(Date:9/30/2014)... Glycodrive , one of the newest ... maximize lean, strong muscle growth with a proprietary blend ... has caught the attention of Shane Michaels, prompting an ... is to help the body use carbohydrates in a ... essential in the muscle-building process, and Glycodrive makes them ...
(Date:9/30/2014)... The American Diabetes Association touts ... their sweet tooth, but the most recent research, published ... that zero-calorie sweeteners may actually be linked to an ... Weizmann Institute of Science in Israel recently discovered ... the mice developed glucose intolerance. They then analyzed data ...
(Date:9/30/2014)... With the flu season upon ... day, it’s a perfect time to announce Jan-Pro’s ... is an electro-static disinfectant delivery system that dries ... missed with spray-on disinfectant applicators. , The EnviroShield ... electrostatic negative charge to the disinfecting solution. ...
(Date:9/30/2014)... Two revolutionary procedures now being utilized by ... disease a far less painful and far more effective ... ever felt electric shock waves surge through your teeth as ... it’s possible you already know the impact of receding gums,” ... dentist in West Palm Beach, and a Fellow in the ...
Breaking Medicine News(10 mins):Health News:Medicaid and Uninsured patients obtain new patient appointments most easily at FQHCs 2Health News:Glycodrive Review Exposes Blue Star Nutraceutical’s Supplement for Leaner, Stronger Muscles 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:Columbus Janitorial Company Announces New Disinfecting System for your workplace 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 3
... NEW YORK, May 29 With the May 26 launch ... inviting consumers to turn their basic daily movements into an ... Nintendo at: http://inr.mediaseed.tv/Nintendo_36542/ After counting ... Walking creates a series of charts and activities to ...
... 500 Company Signs New Leases Keeping Nearly 900 Jobs ... (NYSE: DVA ), a leading provider of ... disease (CKD), today announced it has completed negotiations to ... Avenue as well as at the Columbia Bank Center. ...
... IHSS ProgramSACRAMENTO, Calif., May 29 Gov. Schwarzenegger ... Supportive Services (IHSS) program that would all but ... more than 420,000 low-income elderly, blind and disabled ... individuals--nearly 90 percent of all IHSS consumers--would be ...
... LIONVILLE, Pa., May 29 West Pharmaceutical Services, Inc. ... E. Morel, Jr., Ph.D., Chairman and Chief Executive Officer, ... at the 2009 UBS Global Specialty Pharmaceuticals Conference at ... London, England. A copy of the corporate presentation document ...
... can ease symptoms, raise awareness of breathing patterns , , FRIDAY, ... tree pose a few times a week seems to improve ... In fact, participants in a recent trial studying the effects ... to cut back on some of their asthma medication, said ...
... Former director of the National Institutes of Health (NIH), Elias ... Trustees. Dr. Zerhouni, who directed the NIH from May 2002 ... board member on May 8th in Rochester. "We are very ... Chairman of the Mayo Clinic Board. "He brings a wealth ...
Cached Medicine News:Health News:VIDEO from Medialink and Nintendo: Nintendo Steps Up the Pace With Personal Trainer: Walking 2Health News:DaVita Extends Lease to Maintain Strong Business Presence in Tacoma 2Health News:Schwarzenegger Wants To Eliminate Home Care For 400,000 Elderly, Blind and Disabled Californians 2Health News:Yoga Helps Those With Asthma 2Health News:Former NIH Head Joins Mayo Clinic Trustees 2
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... Enhanced features including aspiration holes ... in laparoscopic procedures requiring precise dissection ... and increased suction demands. ,Flexible ... retractable and nonretractable electrodes and multiple ...
Medicine Products: